ORPP logo
Image from Google Jackets

Atlas of the Diabetic Foot.

By: Contributor(s): Material type: TextTextPublisher: Newark : John Wiley & Sons, Incorporated, 2019Copyright date: ©2017Edition: 3rd edDescription: 1 online resource (264 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781119255284
Subject(s): Genre/Form: Additional physical formats: Print version:: Atlas of the Diabetic FootLOC classification:
  • RC660 .K655 2019
Online resources:
Contents:
Intro -- Title Page -- Copyright Page -- Contents -- Preface to the Third Edition -- Prefaceto the Second Edition -- Prefaceto the First Edition -- Acknowledgements -- About the Companion Website -- Chapter 1 Introduction -- 1.1 Definition -- 1.2 Epidemiology -- 1.3 Economic Aspects -- 1.4 Etiopathogenesis of Foot Problems -- 1.5 Other Risk Factors of Foot Ulceration -- 1.6 Classification of Foot Problems -- References -- Further Reading -- Chapter 2 Diabetic Neuropathy -- 2.1 Methods of Assessing the Foot at Risk -- 2.2 Physical Examination -- 2.2.1 Ancillary Tests -- Further Reading -- Chapter 3 Anatomic Risk Factors for Diabetic Foot Ulceration -- 3.1 Pes Planus or Adult-Acquired Flatfoot Deformity (Flatfoot) -- 3.2 Bunion -- 3.3 Hallux Valgus and Convex Triangular Foot -- 3.4 Bunionette (Tailor's Bunion) -- 3.5 Protruding Interphalangeal Joints -- 3.6 Claw Toes -- 3.7 Prominent Metatarsal Heads -- 3.8 Pes Cavus -- 3.9 Curly Toe -- 3.10 Varus Deformity of the Toes -- 3.11 Talipes Equinus (Clubfoot) -- 3.12 Hammer Toe Deformity -- 3.13 Overriding Toe -- 3.14 Mallet Toe -- 3.15 Charcot Foot -- 3.16 The Consequences of Minor Amputation -- 3.17 Postsurgical Consequences of Hallux Surgery -- 3.18 Toe Disarticulations -- 3.19 Ray Amputations -- 3.20 Transmetatarsal Amputation and Tarsometatarsal (Lisfranc) Disarticulation -- 3.21 Chopart Disarticulation -- Reference -- Further Reading -- Chapter 4 Other Foot-Related Risk Factors -- 4.1 Callus -- 4.1.1 Callus Under Bone Prominence and Dry Skin -- 4.1.2 Callus over Prominent Metatarsal Heads -- 4.1.3 Hemorrhagic Callus -- 4.1.4 Ulcer Under a Callus Area -- 4.1.5 Callus Under a Hallux -- 4.1.6 Callus Due to Bilateral Charcot Foot -- 4.1.7 Callus over the Heel -- 4.1.8 Bilateral Callus Formation -- 4.1.9 Callus Under the Great Toe -- 4.2 Corns -- 4.2.1 Heloma Durum (Hard Corn).
4.2.2 Heloma Molle (Soft Corn) -- 4.2.3 Heloma Molle Complicated by Infection -- 4.3 Nail Deformities -- 4.3.1 Ingrown Nails (Onychocryptosis) -- 4.3.2 Onychodystrophy -- 4.3.3 Onychogryphosis -- 4.4 Edema -- 4.4.1 Edema in a Patient with a Foot Ulcer -- 4.5 Diabetic Bullae (Bullosis Diabeticorum) -- 4.6 Diabetic Thick Skin -- Further Reading -- Chapter 5 Skin and Systemic Diseases with Manifestations in the Feet -- 5.1 Necrobiosis Lipoidica (Necrobiosis Lipoidica Diabeticorum) -- 5.2 Diabetic Dermopathy -- 5.2.1 Warts -- 5.3 Calcium Pyrophosphate Dihydrate Deposition Disease -- 5.4 Psoriasis -- 5.5 Palmoplantar Keratoderma -- 5.6 Hyperkeratotic Eczema -- 5.7 Squamous Cell Carcinoma -- 5.8 Dermatofibrosarcoma Protuberans -- 5.9 Malignant Fibrous Histiocytoma -- 5.10 Malignant Melanoma -- 5.11 Necrotizing Vasculitis -- Further Reading -- Chapter 6 Neuropathic Ulcers -- 6.1 Over a Callus in Various Sites of the Foot -- 6.2 Over a Bony Prominence or in Various Foot Deformities -- 6.3 On a Toe (Tips, or Dorsum of Phalanges) -- 6.4 Over a Metatarsal Head -- 6.5 Heat Injuries -- Further Reading -- Chapter 7 Peripheral Vascular Disease -- 7.1 Non-Invasive Vascular Tests -- 7.1.1 Calculation of the ABI -- 7.1.2 Toe Pressures -- 7.1.3 Transcutaneous Oximetry -- 7.1.4 Segmental Pressure Measurement -- 7.1.5 Segmental Plethysmography -- 7.1.6 Ultrasonography -- 7.1.7 Other Non-Invasive Methods -- 7.2 Invasive Vascular Testing: Arteriography -- Reference -- Further Reading -- Chapter 8 Ischemic and Neuro‐Ischemic Ulcers and Gangrene -- 8.1 Blue toe Syndrome -- 8.2 Critical Limb Ischemia (CLI) -- 8.3 Ischemic Ulcers -- 8.4 Superficial Neuro-Ischemic Ulcers of the Dorsum of the Foot -- 8.5 Diabetic Gangrene ("End-artery" Disease) -- 8.6 Neuro-Ischemic Ulcers of the Toes or Forefoot -- 8.7 Gangrene due to Abscess of the Plantar Space -- 8.8 Wet Gangrene.
8.9 Dry Gangrene -- Further Reading -- Chapter 9 Heel Ulcers -- 9.1 Heel Cracks and Common Diabetic Heel Ulcers -- 9.2 Pressure Ulcers -- 9.3 Staging of Pressure Ulcers -- 9.4 Prevention of Pressure Ulcers -- Further Reading -- Chapter 10 Charcot Foot -- 10.1 Classification of Neuro‐Osteoarthropathy Based on Characteristic Anatomic Patterns of Bone and Joint Destruction -- 10.2 Clinical Presentation and Laboratory Findings -- 10.3 Radiologic Findings -- 10.4 Differential Diagnosis -- 10.5 Treatment -- References -- Further Reading -- Chapter 11 Infections -- 11.1 Classifications for Diabetic Foot Infections -- 11.1.1 Management of the Infected Diabetic Foot -- 11.2 Methods of Appropriate Microbiologic Sampling -- 11.3 Fungal Nail Infections (Onychomycosis) -- 11.4 Paronychia -- 11.5 Superficial Bacterial Foot Infections -- 11.6 Fungal Soft Tissue Infections -- 11.7 Phlegmon -- 11.8 Abscess -- 11.9 Gas Gangrene -- 11.10 Septic Arthritis -- 11.11 Osteomyelitis -- 11.12 Bone Scintigraphy Imaging -- 11.13 Magnetic Resonance Imaging -- 11.14 Antibiotic Treatment -- Further Reading -- Chapter 12 Methods of Prevention -- 12.1 Patient Cases Highlighting the Importance of Avoiding Improper Footwear -- Reference -- Further Reading -- Chapter 13 Methods of Ulcer Healing -- 13.1 Chronic Diabetic Wounds -- 13.2 Wound Bed Preparation -- 13.3 Debridement -- 13.3.1 Surgical Debridement -- 13.3.2 Enzymatic Debridement -- 13.3.3 Biologic Debridement -- 13.3.4 Autolytic Debridement -- 13.4 Dressings -- 13.5 Off‐loading -- 13.5.1 Total-Contact Cast -- 13.5.2 Removable Cast Walkers -- 13.5.3 Instant TCC -- 13.5.4 Half‐shoes -- 13.5.5 Therapeutic Shoes -- 13.5.6 Other Methods for Off-loading -- 13.6 GrowthFactors -- 13.6.1 Platelet-Derived Growth Factor‐β -- 13.6.2 Platelet-Rich Plasma -- 13.6.3 Granulocyte-Colony Stimulating Factor.
13.6.4 Basic Fibroblast Growth Factor -- 13.6.5 Epidermal Growth Factor -- 13.6.6 The LeukoPatch® System -- 13.6.7 Other Growth Factors -- 13.7 Bioengineered Skin Substitutes -- 13.7.1 Graftskin (Apligraf) -- 13.7.2 Dermagraft -- 13.7.3 OrCel -- 13.7.4 Hyalograft 3D and Laserskin Autograft -- 13.7.5 TranCell -- 13.7.6 OASIS -- 13.7.7 GRAFTJACKET -- 13.7.8 AlloDerm -- 13.8 Extracellular matrix proteins -- 13.8.1 Hyaff -- 13.8.2 Collagen -- 13.8.3 Regenerating Agends -- 13.8.4 MMP Modulators -- 13.9 OtherAgents -- 13.9.1 Stem Cell Therapy -- 13.9.2 Alternative Treatments -- 13.9.3 Negative-Pressure Wound Therapy -- 13.9.4 Hyperbaric Oxygen -- FurtherReading -- Chapter 14 Amputations -- 14.1 Amputation of the Toes -- 14.2 Midfoot (Lisfranc and Chopart) Amputations -- 14.3 Hindfoot Amputations -- Further Reading -- Appendix -- Index -- EULA.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Intro -- Title Page -- Copyright Page -- Contents -- Preface to the Third Edition -- Prefaceto the Second Edition -- Prefaceto the First Edition -- Acknowledgements -- About the Companion Website -- Chapter 1 Introduction -- 1.1 Definition -- 1.2 Epidemiology -- 1.3 Economic Aspects -- 1.4 Etiopathogenesis of Foot Problems -- 1.5 Other Risk Factors of Foot Ulceration -- 1.6 Classification of Foot Problems -- References -- Further Reading -- Chapter 2 Diabetic Neuropathy -- 2.1 Methods of Assessing the Foot at Risk -- 2.2 Physical Examination -- 2.2.1 Ancillary Tests -- Further Reading -- Chapter 3 Anatomic Risk Factors for Diabetic Foot Ulceration -- 3.1 Pes Planus or Adult-Acquired Flatfoot Deformity (Flatfoot) -- 3.2 Bunion -- 3.3 Hallux Valgus and Convex Triangular Foot -- 3.4 Bunionette (Tailor's Bunion) -- 3.5 Protruding Interphalangeal Joints -- 3.6 Claw Toes -- 3.7 Prominent Metatarsal Heads -- 3.8 Pes Cavus -- 3.9 Curly Toe -- 3.10 Varus Deformity of the Toes -- 3.11 Talipes Equinus (Clubfoot) -- 3.12 Hammer Toe Deformity -- 3.13 Overriding Toe -- 3.14 Mallet Toe -- 3.15 Charcot Foot -- 3.16 The Consequences of Minor Amputation -- 3.17 Postsurgical Consequences of Hallux Surgery -- 3.18 Toe Disarticulations -- 3.19 Ray Amputations -- 3.20 Transmetatarsal Amputation and Tarsometatarsal (Lisfranc) Disarticulation -- 3.21 Chopart Disarticulation -- Reference -- Further Reading -- Chapter 4 Other Foot-Related Risk Factors -- 4.1 Callus -- 4.1.1 Callus Under Bone Prominence and Dry Skin -- 4.1.2 Callus over Prominent Metatarsal Heads -- 4.1.3 Hemorrhagic Callus -- 4.1.4 Ulcer Under a Callus Area -- 4.1.5 Callus Under a Hallux -- 4.1.6 Callus Due to Bilateral Charcot Foot -- 4.1.7 Callus over the Heel -- 4.1.8 Bilateral Callus Formation -- 4.1.9 Callus Under the Great Toe -- 4.2 Corns -- 4.2.1 Heloma Durum (Hard Corn).

4.2.2 Heloma Molle (Soft Corn) -- 4.2.3 Heloma Molle Complicated by Infection -- 4.3 Nail Deformities -- 4.3.1 Ingrown Nails (Onychocryptosis) -- 4.3.2 Onychodystrophy -- 4.3.3 Onychogryphosis -- 4.4 Edema -- 4.4.1 Edema in a Patient with a Foot Ulcer -- 4.5 Diabetic Bullae (Bullosis Diabeticorum) -- 4.6 Diabetic Thick Skin -- Further Reading -- Chapter 5 Skin and Systemic Diseases with Manifestations in the Feet -- 5.1 Necrobiosis Lipoidica (Necrobiosis Lipoidica Diabeticorum) -- 5.2 Diabetic Dermopathy -- 5.2.1 Warts -- 5.3 Calcium Pyrophosphate Dihydrate Deposition Disease -- 5.4 Psoriasis -- 5.5 Palmoplantar Keratoderma -- 5.6 Hyperkeratotic Eczema -- 5.7 Squamous Cell Carcinoma -- 5.8 Dermatofibrosarcoma Protuberans -- 5.9 Malignant Fibrous Histiocytoma -- 5.10 Malignant Melanoma -- 5.11 Necrotizing Vasculitis -- Further Reading -- Chapter 6 Neuropathic Ulcers -- 6.1 Over a Callus in Various Sites of the Foot -- 6.2 Over a Bony Prominence or in Various Foot Deformities -- 6.3 On a Toe (Tips, or Dorsum of Phalanges) -- 6.4 Over a Metatarsal Head -- 6.5 Heat Injuries -- Further Reading -- Chapter 7 Peripheral Vascular Disease -- 7.1 Non-Invasive Vascular Tests -- 7.1.1 Calculation of the ABI -- 7.1.2 Toe Pressures -- 7.1.3 Transcutaneous Oximetry -- 7.1.4 Segmental Pressure Measurement -- 7.1.5 Segmental Plethysmography -- 7.1.6 Ultrasonography -- 7.1.7 Other Non-Invasive Methods -- 7.2 Invasive Vascular Testing: Arteriography -- Reference -- Further Reading -- Chapter 8 Ischemic and Neuro‐Ischemic Ulcers and Gangrene -- 8.1 Blue toe Syndrome -- 8.2 Critical Limb Ischemia (CLI) -- 8.3 Ischemic Ulcers -- 8.4 Superficial Neuro-Ischemic Ulcers of the Dorsum of the Foot -- 8.5 Diabetic Gangrene ("End-artery" Disease) -- 8.6 Neuro-Ischemic Ulcers of the Toes or Forefoot -- 8.7 Gangrene due to Abscess of the Plantar Space -- 8.8 Wet Gangrene.

8.9 Dry Gangrene -- Further Reading -- Chapter 9 Heel Ulcers -- 9.1 Heel Cracks and Common Diabetic Heel Ulcers -- 9.2 Pressure Ulcers -- 9.3 Staging of Pressure Ulcers -- 9.4 Prevention of Pressure Ulcers -- Further Reading -- Chapter 10 Charcot Foot -- 10.1 Classification of Neuro‐Osteoarthropathy Based on Characteristic Anatomic Patterns of Bone and Joint Destruction -- 10.2 Clinical Presentation and Laboratory Findings -- 10.3 Radiologic Findings -- 10.4 Differential Diagnosis -- 10.5 Treatment -- References -- Further Reading -- Chapter 11 Infections -- 11.1 Classifications for Diabetic Foot Infections -- 11.1.1 Management of the Infected Diabetic Foot -- 11.2 Methods of Appropriate Microbiologic Sampling -- 11.3 Fungal Nail Infections (Onychomycosis) -- 11.4 Paronychia -- 11.5 Superficial Bacterial Foot Infections -- 11.6 Fungal Soft Tissue Infections -- 11.7 Phlegmon -- 11.8 Abscess -- 11.9 Gas Gangrene -- 11.10 Septic Arthritis -- 11.11 Osteomyelitis -- 11.12 Bone Scintigraphy Imaging -- 11.13 Magnetic Resonance Imaging -- 11.14 Antibiotic Treatment -- Further Reading -- Chapter 12 Methods of Prevention -- 12.1 Patient Cases Highlighting the Importance of Avoiding Improper Footwear -- Reference -- Further Reading -- Chapter 13 Methods of Ulcer Healing -- 13.1 Chronic Diabetic Wounds -- 13.2 Wound Bed Preparation -- 13.3 Debridement -- 13.3.1 Surgical Debridement -- 13.3.2 Enzymatic Debridement -- 13.3.3 Biologic Debridement -- 13.3.4 Autolytic Debridement -- 13.4 Dressings -- 13.5 Off‐loading -- 13.5.1 Total-Contact Cast -- 13.5.2 Removable Cast Walkers -- 13.5.3 Instant TCC -- 13.5.4 Half‐shoes -- 13.5.5 Therapeutic Shoes -- 13.5.6 Other Methods for Off-loading -- 13.6 GrowthFactors -- 13.6.1 Platelet-Derived Growth Factor‐β -- 13.6.2 Platelet-Rich Plasma -- 13.6.3 Granulocyte-Colony Stimulating Factor.

13.6.4 Basic Fibroblast Growth Factor -- 13.6.5 Epidermal Growth Factor -- 13.6.6 The LeukoPatch® System -- 13.6.7 Other Growth Factors -- 13.7 Bioengineered Skin Substitutes -- 13.7.1 Graftskin (Apligraf) -- 13.7.2 Dermagraft -- 13.7.3 OrCel -- 13.7.4 Hyalograft 3D and Laserskin Autograft -- 13.7.5 TranCell -- 13.7.6 OASIS -- 13.7.7 GRAFTJACKET -- 13.7.8 AlloDerm -- 13.8 Extracellular matrix proteins -- 13.8.1 Hyaff -- 13.8.2 Collagen -- 13.8.3 Regenerating Agends -- 13.8.4 MMP Modulators -- 13.9 OtherAgents -- 13.9.1 Stem Cell Therapy -- 13.9.2 Alternative Treatments -- 13.9.3 Negative-Pressure Wound Therapy -- 13.9.4 Hyperbaric Oxygen -- FurtherReading -- Chapter 14 Amputations -- 14.1 Amputation of the Toes -- 14.2 Midfoot (Lisfranc and Chopart) Amputations -- 14.3 Hindfoot Amputations -- Further Reading -- Appendix -- Index -- EULA.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

to post a comment.

© 2024 Resource Centre. All rights reserved.